Related articles

  • Clinical Trial

    Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality.

    Biol. Blood Marrow Transplant. 2009 Aug 1;15(8):919-29.

  • Clinical Trial

    An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients.

    Biol. Blood Marrow Transplant. 2010 Mar 1; 16 (3): 333-43.

  • Article

    Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.

    Am. J. Hematol. 2015 Feb 1; 90 (2): 144-8.

    • Show more related articles...